low dose lung CT (LDLCT)
Jump to navigation
Jump to search
Indications
- USPSTF recommends annual screening for lung cancer with low-dose CT for adults aged 50-80 with a 20-pack-year smoking history who currently smoke or have quit within the past 15 years[1]
* see screening for lung cancer
Adverse effects
Procedure
Notes
- the most common incidental findings:[3]
- emphysema 43%
- coronary artery calcium 12%
- mass lesions 7%
More general terms
References
- ↑ Jump up to: 1.0 1.1 US Preventive Services Task Force Screening for Lung Cancer. US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(10):962-970. March 9. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33687470 https://jamanetwork.com/journals/jama/fullarticle/2777244
Jonas DE, Reuland DS, Reddy SM et al Screening for Lung Cancer With Low-Dose Computed Tomography. Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2021;325(10):971-987. March 9. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33687468 https://jamanetwork.com/journals/jama/fullarticle/2777242
Meza R, Jeon J, Toumazis I et al Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force. JAMA. 2021;325(10):988-997. March 9 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33687469 https://jamanetwork.com/journals/jama/fullarticle/2777243
Henderson LM, Rivera MP, Basch E Broadened Eligibility for Lung Cancer Screening. Challenges and Uncertainty for Implementation and Equity. JAMA. 2021;325(10):939-941. March 9 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33687453 https://jamanetwork.com/journals/jama/fullarticle/2777223
Colson YL, Shepard JO, Lennes IT. New USPSTF guidelines for lung cancer screening: Better but not enough. JAMA Surg 2021 Mar 9; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33687427 https://jamanetwork.com/journals/jamasurgery/fullarticle/2777052
Fukunaga M et al. The 2021 US Preventive Services Task Force recommendation on lung cancer screening: The more things stay the same... JAMA Oncol 2021 Mar 9; [e-pub] PMID: https://www.ncbi.nlm.nih.gov/pubmed/33687430 https://jamanetwork.com/journals/jamaoncology/fullarticle/2777056
Moyer VA et al Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. Published online 31 December 2013 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24378917 <Internet> http://annals.org/article.aspx?articleid=1809422
Bach PB Raising the Bar for the U.S. Preventive Services Task Force. Ann Intern Med. Published online 31 December 2013 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24379087 <Internet> http://annals.org/article.aspx?articleid=1809426
Detterbeck FC and Unger M Screening for Lung Cancer: Moving Into a New Era. Ann Intern Med. Published online 31 December 2013 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24379025 <Internet> http://annals.org/article.aspx?articleid=1809425 - ↑ Jump up to: 2.0 2.1 Rampinelli C, De Marco P, Origgi D et al Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis. BMJ 2017;356:j347 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28179230 Free full text <Internet> http://www.bmj.com/content/356/bmj.j347
- ↑ Jump up to: 3.0 3.1 Gareen IF et al. Significant incidental findings in the National Lung Screening Trial. JAMA Intern Med 2023 May 8; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/37155190 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2804380